Published in Immunology on December 01, 1999
Immunity to murine chlamydial genital infection. Infect Immun (2002) 4.64
Intracellular adhesion molecule 1 plays a key role in acquired immunity to salmonellosis. Infect Immun (2003) 1.32
Plac8-dependent and inducible NO synthase-dependent mechanisms clear Chlamydia muridarum infections from the genital tract. J Immunol (2012) 1.03
Chemokine and chemokine receptor dynamics during genital chlamydial infection. Infect Immun (2002) 1.01
Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect Immun (2000) 0.97
Immunization with a MOMP-based vaccine protects mice against a pulmonary Chlamydia challenge and identifies a disconnection between infection and pathology. PLoS One (2013) 0.79
Intercellular adhesion molecule-1 is required for the early formation of granulomas and participates in the resistance of mice to the infection with the fungus Paracoccidioides brasiliensis. Am J Pathol (2006) 0.77
Exploiting induced pluripotent stem cell-derived macrophages to unravel host factors influencing Chlamydia trachomatis pathogenesis. Nat Commun (2017) 0.75
Integrins: versatility, modulation, and signaling in cell adhesion. Cell (1992) 34.06
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med (1987) 6.45
Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol (1995) 6.09
Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun (1986) 4.34
Structure and function of leukocyte integrins. Immunol Rev (1990) 3.62
Inflammatory and immune responses are impaired in mice deficient in intercellular adhesion molecule 1. Proc Natl Acad Sci U S A (1993) 3.57
Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection. Infect Immun (1988) 3.55
CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun (1995) 3.45
Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med (1994) 3.32
Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur J Immunol (1996) 3.24
Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J Exp Med (1989) 3.16
Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun (1997) 3.12
Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol (1994) 3.06
Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun (1997) 2.46
Kinetic and affinity limits on antibodies produced during immune responses. Proc Natl Acad Sci U S A (1995) 2.41
Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect Immun (1995) 2.28
Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med (1998) 2.19
LFA-1-deficient mice show normal CTL responses to virus but fail to reject immunogenic tumor. J Exp Med (1996) 2.14
Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol (1996) 2.11
Diversity of the immunoglobulin gene superfamily. Adv Immunol (1989) 1.81
Chlamydia trachomatis genital infections--United States, 1995. MMWR Morb Mortal Wkly Rep (1997) 1.62
Susceptibility to reinfection after a primary chlamydial genital infection is associated with a decrease of antigen-specific T cells in the genital tract. Infect Immun (1991) 1.58
Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun (1998) 1.47
CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol (1994) 1.43
Internalization of Chlamydia by dendritic cells and stimulation of Chlamydia-specific T cells. J Immunol (1998) 1.35
The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. Immunology (1996) 1.31
Route of infection that induces a high intensity of gamma interferon-secreting T cells in the genital tract produces optimal protection against Chlamydia trachomatis infection in mice. Infect Immun (1998) 1.29
Pathogenesis of pelvic inflammatory disease. What are the questions? JAMA (1991) 1.23
Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection. J Med Microbiol (1998) 1.18
Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia. J Leukoc Biol (1996) 1.12
Characterization of the function of intercellular adhesion molecule (ICAM)-3 and comparison with ICAM-1 and ICAM-2 in immune responses. J Exp Med (1994) 1.12
Distinct binding of T lymphocytes to ICAM-1, -2 or -3 upon activation of LFA-1. Eur J Immunol (1994) 1.12
An in vitro model for immune control of chlamydial growth in polarized epithelial cells. Infect Immun (1994) 1.08
Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun (1998) 1.07
Impaired immune responses toward alloantigens and tumor cells but normal thymic selection in mice deficient in the beta2 integrin leukocyte function-associated antigen-1. J Immunol (1996) 1.06
Immune control of Chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that include nitric oxide induction, tryptophan catabolism and iron deprivation. Microbiol Immunol (1998) 1.04
Chlamydia trachomatis: a major threat to reproduction. Hum Reprod (1989) 1.00
The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions. Immunol Res (1998) 1.00
From naive to memory. Development and regulation of CD4+ T cell responses. Immunol Res (1998) 0.99
The effect of atrophy, hyperplasia, and keratinization accompanying the estrous cycle on Langerhans' cells in mouse vaginal epithelium. Am J Anat (1985) 0.91
Interactions between epithelial cells and T lymphocytes: role of adhesion molecules. J Leukoc Biol (1990) 0.88
Pelvic inflammatory disease. Infect Dis Clin North Am (1994) 0.86
Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes. J Virol (1991) 0.84
Costimulating factors and signals relevant for antigen presenting cell function. Adv Exp Med Biol (1993) 0.81
Adhesion molecules: co-stimulators and co-mitogens in dendritic cell-T cell interaction. Adv Exp Med Biol (1993) 0.78
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet (1996) 26.06
The transcriptional program in the response of human fibroblasts to serum. Science (1999) 19.19
"Hypervitaminosis" and "vitamin balance". Biochem J (1928) 15.32
Vitamin A and carotene: The distribution of vitamin A in the organs of the normal and hypervitaminotic rat. Biochem J (1934) 5.81
The effect of vitamin B deficiency upon the vitamin A reserves of the rat. Biochem J (1931) 4.25
Open-reading-frame sequence tags (OSTs) support the existence of at least 17,300 genes in C. elegans. Nat Genet (2001) 4.03
The vitamin A content and toxicity of bear and seal liver. Biochem J (1943) 3.75
Failure of voluntary testing for human immunodeficiency virus to identify infected parturient women in a high-risk population. N Engl J Med (1988) 3.56
CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem (2001) 3.28
Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) (2004) 3.12
Vitamin A and carotene: The vitamin A reserves of the human infant and child in health and disease. Biochem J (1937) 3.10
The excretion of vitamin A in urine. Biochem J (1941) 3.06
Evaluation of polymerase chain reaction for diagnosis of pneumococcal pneumonia. J Clin Microbiol (1993) 3.04
Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility. Br Med J (Clin Res Ed) (1983) 2.86
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis (2003) 2.85
A disease severity scale for systemic sclerosis: development and testing. J Rheumatol (1999) 2.85
Circulating endothelin-1 levels in systemic sclerosis subsets--a marker of fibrosis or vascular dysfunction? J Rheumatol (1994) 2.76
The specificity of fetal IgM: antibody or anti-antibody? Ann N Y Acad Sci (1975) 2.65
Eye movements modulate visual receptive fields of V4 neurons. Neuron (2001) 2.60
Treatment of stress incontinence by maximum perineal electrical stimulation. Br Med J (1967) 2.60
Altered imprinted gene methylation and expression in completely ES cell-derived mouse fetuses: association with aberrant phenotypes. Development (1998) 2.60
The chemical estimation of vitamin E in vegetable oils. Biochem J (1945) 2.58
Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol (1976) 2.49
European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis (2001) 2.49
The Feeding of Xanthophyll to Rats on a Diet Deficient in Vitamin A. Biochem J (1927) 2.45
The promise of integrated representative surveys about sexually transmitted diseases and behavior. Sex Transm Dis (1997) 2.44
Vitamin A and carotene: The elimination of vitamin A from the livers of rats previously given massive doses of vitamin A concentrate. Biochem J (1935) 2.44
The incidence of acute brain injury and serious impairment in a defined population. Am J Epidemiol (1984) 2.43
Randomized, prospective, placebo-controlled trial of bosentan in interstitial lung disease secondary to systemic sclerosis. Arthritis Rheum (2010) 2.37
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun (1993) 2.32
Bosentan treatment for pulmonary arterial hypertension related to connective tissue disease: a subgroup analysis of the pivotal clinical trials and their open-label extensions. Ann Rheum Dis (2006) 2.28
Evaluation of bias in diagnostic-test sensitivity and specificity estimates computed by discrepant analysis. J Clin Microbiol (1998) 2.14
Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM (2007) 2.14
The Conglutination Complement-Fixation Test as a Supplementary Method of Detecting Activity with Brucella Abortus Antigens. Can J Comp Med Vet Sci (1952) 2.08
Brucella Infection of Buffalo and Elk. Can J Comp Med Vet Sci (1947) 2.07
Role of superoxide dismutase and catalase as determinants of pathogenicity of Nocardia asteroides: importance in resistance to microbicidal activities of human polymorphonuclear neutrophils. Infect Immun (1985) 2.06
Evaluation of nucleic acid amplification tests as reference tests for Chlamydia trachomatis infections in asymptomatic men. J Clin Microbiol (2000) 2.02
Hypervitaminosis and vitamin balance: Part II. The specificity of vitamin D in irradiated ergosterol poisoning. Part III. The pathology of hypervitaminosis D. Biochem J (1929) 2.01
Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol (1997) 2.00
Viability of Brucella Abortus Strain 19. Can J Comp Med Vet Sci (1942) 1.99
Serological Investigations of Leptospirosis in Canada. I. Introduction and Preliminary Complement-Fixation Studies of Cattle Sera With Commercially-Prepared Leptospira Pomona Antigen. Can J Comp Med Vet Sci (1956) 1.97
Hematocrit, volume expander, temperature, and shear rate effects on blood viscosity. Anesth Analg (2000) 1.94
Mycophenolate mofetil in diffuse cutaneous systemic sclerosis--a retrospective analysis. Rheumatology (Oxford) (2006) 1.94
Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr (1985) 1.92
The absorption spectra of the mixed fatty acids from cod-liver oil. Biochem J (1933) 1.90
The impact of a clinic-based literacy intervention on language development in inner-city preschool children. Pediatrics (2001) 1.90
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis (2000) 1.89
Missense mutations in the most ancient residues of the PAX6 paired domain underlie a spectrum of human congenital eye malformations. Hum Mol Genet (1999) 1.86
Childhood-onset scleroderma: is it different from adult-onset disease. Arthritis Rheum (1996) 1.85
Imatinib for the treatment of refractory, diffuse systemic sclerosis. Rheumatology (Oxford) (2008) 1.83
Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol (1988) 1.83
Deletion of a silencer element in Igf2 results in loss of imprinting independent of H19. Nat Genet (2000) 1.83
Urinary infection in the elderly. Geriatrics (1969) 1.82
Comparison of arbitrarily primed polymerase chain reaction, ribotyping, and monoclonal antibody analysis for subtyping Legionella pneumophila serogroup 1. J Clin Microbiol (1993) 1.82
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) (2001) 1.82
Sensing of aromatic compounds by the DmpR transcriptional activator of phenol-catabolizing Pseudomonas sp. strain CF600. J Bacteriol (1994) 1.78
A pilot study of the prevalence of chlamydial infection in a national household survey. Sex Transm Dis (1998) 1.78
Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet (1991) 1.76
Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet (1991) 1.76
Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem (2000) 1.74
Systemic sclerosis associated pulmonary hypertension: improved survival in the current era. Heart (2005) 1.73
A 1.1-Mb transcript map of the hereditary hemochromatosis locus. Genome Res (1997) 1.71
Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis. Infect Immun (1995) 1.70
Evaluation of thirty-one mouse monoclonal antibodies to human IgG epitopes. Hybridoma (1984) 1.67
Differential accumulation of transcripts for four tomato 1-aminocyclopropane-1-carboxylate synthase homologs under various conditions. Proc Natl Acad Sci U S A (1992) 1.67
Anti-RNA polymerases and other autoantibody specificities in systemic sclerosis. Br J Rheumatol (1998) 1.66
Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma. Rheumatology (Oxford) (2001) 1.66
Equine Encephalomyelitis Virus. Can J Comp Med Vet Sci (1940) 1.65
Targeting of proteins to the outer envelope membrane uses a different pathway than transport into chloroplasts. Plant Cell (1991) 1.63
The source and role of RANTES in interstitial lung disease. Eur Respir J (1997) 1.62
Typing of Chlamydia trachomatis strains from urine samples by amplification and sequencing the major outer membrane protein gene (omp1). Sex Transm Infect (2001) 1.62
myo-inositol pentakisphosphates. Structure, biological occurrence and phosphorylation to myo-inositol hexakisphosphate. Biochem J (1991) 1.57
Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis (1983) 1.55
Immunohistochemical localization of transforming growth factor-beta 1 in the lungs of patients with systemic sclerosis, cryptogenic fibrosing alveolitis and other lung disorders. Histopathology (1994) 1.54
Connexin 50 mutation in a family with congenital "zonular nuclear" pulverulent cataract of Pakistani origin. Hum Genet (1999) 1.54
The use of infra-red thermography in a rheumatology unit. Br J Rheumatol (1990) 1.53
Cloning and expression of a protective antigen from the cattle tick Boophilus microplus. Proc Natl Acad Sci U S A (1989) 1.53
Climatic modifiers of the response to nitrogen deposition in peat-forming Sphagnum mosses: a meta-analysis. New Phytol (2011) 1.53
Carcinoembryonic antigen (CEA) in colonic cancer. Use in preoperative and postoperative diagnosis and prognosis. JAMA (1972) 1.51
Fearon's "Pyrogallol" Test as a Possible Basis for the Estimation of Vitamin A. Biochem J (1926) 1.51
Glasshouse vs field experiments: do they yield ecologically similar results for assessing N impacts on peat mosses? New Phytol (2012) 1.51
Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1. J Invest Dermatol (2001) 1.51
Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med (1994) 1.49
Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease. Am J Pathol (1997) 1.47
Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun (1998) 1.47
Doxycycline and azithromycin for prevention of chlamydial persistence or recurrence one month after treatment in women. A use-effectiveness study in public health settings. Sex Transm Dis (1998) 1.46
Effects of Various Agents on Colour Tests for Vitamin A. Biochem J (1926) 1.46
Vaccination of Sexually Mature Cows with Brucella abortus Strain 19: I. Negative Cows Contained in Negative Dairy Herds. Can J Comp Med Vet Sci (1948) 1.46
Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum (1999) 1.45
Progress in systemic sclerosis: a 10-year perspective. Rheumatology (Oxford) (2009) 1.44
Clearance of inhaled technetium-99m-DTPA as a clinical index of pulmonary vascular disease in systemic sclerosis. Eur Respir J (1999) 1.44
Assessment of endothelial function in complex regional pain syndrome type I using iontophoresis and laser Doppler imaging. Rheumatology (Oxford) (2004) 1.44
Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: potential for cellular vaccine development. J Immunol (2000) 1.42